Bacteremia Staph
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia (NCT05184764) | Armata Pharmaceuticals, Inc. | 2022-04-26 |
Track Bacteremia Staph automatically
Every clearance here is in the API, with alerts when new ones post.